Response
In response to the letter of Lim, Patel, and Lip, allow me to respond for the writing group that produced the summary conference on definition of the metabolic syndrome sponsored by the National Heart, Lung and Blood Institute (NHLBI) and American Heart Association (AHA). 1 We appreciate your interest in this conference and your willingness to comment in writing.
First, there is an enormous body of data of many types that document that obesity is accompanied by an increase in metabolic risk factors that predispose to cardiovascular disease. 2 These risk factors include higher cholesterol and triglyceride, lower high-density lipoprotein (HDL), higher blood pressure, insulin resistance, and elevated glucose, including type 2 diabetes. Moreover, obesity is accompanied by several other emerging risk factors that underlie a prothrombotic state and a proinflammatory state. 3 Finally, several prospective studies show that obesity is associated with increased risk for cardiovascular disease. 3 The National Cholesterol Education Program (NCEP) 3 views the metabolic syndrome as the constellation of cardiovascular risk factors that often accompany obesity.
The NCEP 3 has not attempted to define the complex pathophysiological pathways that link obesity to the metabolic syndrome. A great deal of research is being carried out to better understand these pathways, but our knowledge is far from complete. Nevertheless, existing data strongly suggest that many persons are genetically predisposed to insulin resistance and other cardiovascular risk factors. When these people become obese, they are more likely to develop the metabolic syndrome in its more severe forms. Finally, the NCEP recommended using waist circumference as an indicator of obesity rather than body mass index. 3 It noted that definitions of a high waist circumference vary in different populations.
